Euformatics offers high standard bioinformatics tools to interpret sequence data. Our one single test can provide all the cancer-relevant
Euformatics has raised $365K in total funding. The most recent round was Grant. The last funding was announced in July 2022.
Euformatics's investors include European Commission.
Euformatics is headquartered in Espoo, Finland.
Euformatics offers high standard bioinformatics tools to interpret sequence data. Our one single test can provide all the cancer-relevant
Euformatics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Euformatics — Funding & Investors." VCBacked, July 1, 2022, https://www.vcbacked.co/company/euformatics. Accessed September 30, 2026.
VCBacked. (2022). Euformatics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/euformatics
{{cite web |title=Euformatics — Funding & Investors |url=https://www.vcbacked.co/company/euformatics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated